Filing Flows › CareDx (CDNA) › Testing services revenue revenue
CareDx (CDNA) Testing services revenue revenue by quarter
CareDx's Testing services revenue revenue was $119M in Q3 2026 (third quarter 2026), +19% from Q2 2026. Over the last 7 quarters it ranged from $61.9M (Q1 2025) to $119M (Q3 2026).
| Quarter | Testing services revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $119M | +19% | +65% |
| Q2 2026 | $99.9M | +9% | +61% |
| Q1 2026 | $91.4M | +17% | +48% |
| Q4 2025 | $78.4M | +9% | — |
| Q3 2025 | $72.2M | +16% | — |
| Q2 2025 | $62.0M | +0.2% | — |
| Q1 2025 | $61.9M | — | — |
Q3 2026 at a glance
CareDx, Q3 2026: revenue $139M (+39% year over year), operating margin 5.8%, net earnings $19.3M, operating cash flow $12.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is CareDx's Testing services revenue revenue?
CareDx's Testing services revenue revenue was $119M in Q3 2026 (third quarter 2026), +19% from Q2 2026.
How has CareDx's Testing services revenue revenue changed?
Over the last 7 quarters it ranged from $61.9M (Q1 2025) to $119M (Q3 2026).